Susan G Hilsenbeck Selected Research

CELF1 Protein

11/2016

CELF1 is a central node in post-transcriptional regulatory programmes underlying EMT.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susan G Hilsenbeck Research Topics

Disease

94	Neoplasms (Cancer) 10/2022 - 05/2002
93	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2002
14	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2004
11	Carcinogenesis 01/2015 - 05/2002
8	Triple Negative Breast Neoplasms 12/2021 - 03/2011
3	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2022 - 10/2007
3	Prostatic Neoplasms (Prostate Cancer) 11/2017 - 05/2010
3	Hyperplasia 10/2007 - 01/2006
2	Leukemia 10/2022 - 01/2019
2	Pathologic Complete Response 01/2020 - 01/2011
2	Arthralgia (Joint Pain) 09/2019 - 01/2018
2	Adenocarcinoma 01/2019 - 02/2012
2	Carcinoma (Carcinomatosis) 01/2019 - 06/2013
2	Tics (Tic) 10/2014 - 02/2012
2	Shock 02/2009 - 02/2008
2	Erythema 09/2006 - 05/2002
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022
1	Lymphoma (Lymphomas) 10/2022
1	Ductal Carcinoma 01/2022

Drug/Important Bio-Agent (IBA)

38	Estrogen ReceptorsIBA 01/2022 - 09/2002
22	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2002
21	Tamoxifen FDA LinkGeneric 01/2021 - 03/2003
16	Lapatinib (GW572016)FDA Link 05/2021 - 05/2008
15	Progesterone Receptors (Progesterone Receptor)IBA 01/2022 - 03/2003
15	Trastuzumab (Herceptin)FDA Link 05/2021 - 12/2003
11	Phosphotransferases (Kinase)IBA 01/2021 - 10/2002
9	Estrogens (Estrogen)FDA Link 01/2021 - 10/2002
9	Hormones (Hormone)IBA 09/2019 - 04/2004
9	ErbB Receptors (EGF Receptor)IBA 11/2015 - 02/2006
9	Docetaxel (Taxotere)FDA Link 01/2012 - 08/2003
8	Estrogen Receptor alphaIBA 01/2021 - 09/2002
7	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2021 - 04/2005
7	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2006
7	Phenobarbital (Luminal)FDA Link 11/2015 - 09/2008
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2005
6	Messenger RNA (mRNA)IBA 01/2020 - 01/2006
6	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2018 - 01/2011
5	Transcription Factors (Transcription Factor)IBA 01/2020 - 10/2002
5	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2016 - 10/2002
5	Bexarotene (LGD1069)FDA Link 02/2009 - 05/2002
4	IntegrinsIBA 01/2020 - 07/2011
4	Co-Repressor ProteinsIBA 01/2020 - 01/2006
4	Pharmaceutical PreparationsIBA 01/2018 - 07/2011
4	human ERBB2 proteinIBA 09/2014 - 02/2006
4	Small Interfering RNA (siRNA)IBA 07/2014 - 12/2009
4	Insulin-Like Growth Factor I (IGF-1)IBA 02/2012 - 09/2008
4	Protein Isoforms (Isoforms)IBA 06/2011 - 04/2004
4	Tyrosine Kinase InhibitorsIBA 04/2011 - 09/2008
3	Formaldehyde (Formol)FDA Link 01/2022 - 10/2006
3	ParaffinIBA 01/2022 - 10/2006
3	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 05/2010
3	Aromatase InhibitorsIBA 01/2021 - 01/2018
3	Estradiol (Delestrogen)FDA LinkGeneric 01/2021 - 02/2012
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 09/2014
3	Letrozole (Femara)FDA LinkGeneric 01/2020 - 08/2009
3	CarcinogensIBA 10/2019 - 05/2002
3	Fulvestrant (Faslodex)FDA Link 01/2019 - 07/2014
3	Interleukin-8 (Interleukin 8)IBA 10/2016 - 06/2013
3	DNA (Deoxyribonucleic Acid)IBA 03/2016 - 06/2007
3	Biological ProductsIBA 01/2015 - 06/2007
3	ClaudinsIBA 10/2014 - 08/2009
3	RetinoidsIBA 04/2005 - 05/2002
2	neratinibIBA 05/2021 - 09/2017
2	Leucine (L-Leucine)FDA Link 01/2021 - 01/2020
2	ChromatinIBA 01/2020 - 10/2016
2	Tyrosine (L-Tyrosine)FDA Link 01/2018 - 03/2011
2	CytokinesIBA 01/2018 - 06/2013
2	TenascinIBA 11/2017 - 11/2015
2	Indicators and Reagents (Reagents)IBA 03/2016 - 01/2016
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016 - 10/2002
2	LigandsIBA 05/2015 - 12/2006
2	TensinsIBA 09/2014 - 01/2011
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2014 - 01/2010
2	Interleukin-6 (Interleukin 6)IBA 06/2013 - 02/2008
2	Insulin-Like PeptidesIBA 02/2012 - 04/2011
2	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 04/2011 - 01/2010
2	rho GTPase-activating proteinIBA 01/2010 - 01/2009
2	Growth Factor ReceptorsIBA 01/2010 - 02/2006
2	Gefitinib (Iressa)FDA Link 02/2009 - 09/2008
2	Doxycycline (Periostat)FDA LinkGeneric 06/2008 - 10/2002
2	Retinoid X Receptors (Retinoid X Receptor)IBA 04/2005 - 11/2002
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2022
1	fludarabineIBA 10/2022
1	Vorinostat FDA Link 10/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2022
1	Decitabine FDA Link 10/2022
1	Apoptosis Regulatory ProteinsIBA 01/2022
1	venetoclaxIBA 01/2022
1	pertuzumabIBA 05/2021
1	palbociclibIBA 01/2021
1	Cyclin-Dependent Kinase 4IBA 01/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021

Therapy/Procedure

52	Therapeutics 10/2022 - 03/2003
15	Drug Therapy (Chemotherapy) 12/2021 - 08/2003
4	Aftercare (After-Treatment) 11/2015 - 02/2005
3	Radiotherapy 05/2018 - 10/2010
3	Transplantation 10/2014 - 01/2009
2	Chemoprevention 12/2013 - 06/2013
2	Resuscitation 02/2009 - 02/2008
2	Neoadjuvant Therapy 05/2008 - 02/2005